Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast
Intra-Cellular Therapies (Nasdaq: ITCI) announced a conference call on May 4, 2023, at 8:30 a.m. ET to discuss its financial results for Q1 2023. The company focuses on therapeutics for central nervous system disorders, leveraging Nobel prize-winning research to develop innovative treatments for complex psychiatric and neurologic diseases.
The call will provide a corporate update and delve into the financial performance for the quarter ended March 31, 2023. Participants must register in advance via a provided link, and both live and archived webcasts will be accessible on the company's website.
- Upcoming conference call on May 4, 2023, to discuss financial results potentially indicating transparency.
- Focus on innovative treatments based on Nobel prize-winning research, highlighting a strong scientific foundation.
- None.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, May 4, 2023, to provide a corporate update and discuss details of the Company's financial results for the quarter ended March 31, 2023.
To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.
The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006
FAQ
What are the details of Intra-Cellular Therapies' upcoming conference call?
How can I attend the Intra-Cellular Therapies conference call?
Where can I find the archived webcast of the Intra-Cellular Therapies conference call?
What does Intra-Cellular Therapies focus on?
